WHO Webinar: How can we ensure access to effective asthma and COPD care for all who need it?

Asthma and COPD are the two main chronic respiratory diseases included in the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2030. 

COPD is the third leading cause of death globally. In 2019, 3.2 million people died from COPD, while 0.5 million people died from asthma. The Global Burden of Disease Survey 2019 estimates that 262 million people are affected by asthma, and 212 million by COPD.

Asthma is the commonest chronic disease in children and is responsible for considerable morbidity: uncontrolled symptoms lead to absence from school and work, emergency health care visits, and associated costs for people living with asthma, their families, and the wider community.

The effective treatment of asthma and COPD relies on the availability of inhaled medicines, both for emergency and long-term management. However, access to safe, effective, quality-assured, and affordable inhalers is a problem is many countries. 

During the webinar we will 
• Share the latest data relating to availability of inhaled asthma and COPD medicines and diagnostic tools
• Learn from country experiences
• Discuss the action required by key stakeholders to address the challenges

We are delighted to welcome colleagues from several international respiratory groups and the Global Alliance against Chronic Respiratory Diseases, including the ICPRG President-Elect Prof. Khoo Ee Ming.

Register for free here. The session will be recorded and shared with attendees afterward.